Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

Change Healthcare $2B sale could accelerate UnitedHealth Group’s M&A plans

The news: Change Healthcare is in advanced talks to sell its payment integrity business (ClaimsXten) for more than $2 billion, per Bloomberg.

  • ClaimsXten automates claim reviews and medical code auditing to help insurers provide accurate reimbursement to physicians.
  • The sale will only occur if UnitedHealth Group’s (UHG) analytics arm, Optum, completes its acquisition of Change Healthcare this year.

How we got here: The DOJ has blocked the UHG-Change Healthcare deal over anti-competitive concerns.

In January 2021, UHG’s Optum revealed plans to buy health IT company Change Healthcare in a megadeal valued at $8 billion.

  • Shortly after, the American Hospital Association (AHA) urged the DOJ to investigate the agreement due to competition and reimbursement concerns.
  • The AHA said Optum would have “strong financial incentives to use competitive payers’ data to inform its reimbursement rates.” That would harm hospitals and providers.
  • In February of this year, the DOJ responded to the AHA’s concerns by filing a civil lawsuit to block the merger.
  • UHG agreed to postpone the Change Healthcare deal to the end of 2022.

The problem: The DOJ says the Change-Optum deal would give UHG a monopoly over healthcare data and stifle innovation in the health IT market.

If combined, Optum and Change Healthcare could become a healthcare analytics giant.

  • Change Healthcare processes over $1.5 trillion in healthcare claims annually.
  • That’s over 33% of all US patient records.
  • Optum’s footprint already includes 250 health plans and 100,000 US providers, per UHG. For comparison, insurer and provider network Kaiser Permanente only employs 9,000 physicians, per its website.

The big takeaway: The DOJ could back off if UHG agrees to sell Change’s payment business post-merger, though.

  • ClaimsXten is a large revenue driver for Change, and integrating it into UHG’s business would make it an even bigger competitive threat to rivals like Cigna and Humana.
  • In fact, ClaimsXten brings in $150 million in revenues annually for Change Healthcare.
  • So, selling off the payments business could help convince the DOJ to halt its probe and let UHG complete its Optum-Change deal before the end of this year.